MedPath

Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer

Phase 4
Completed
Conditions
Climacteric Syndrome
Interventions
Device: acupuncture
Other: self care
Registration Number
NCT01275807
Lead Sponsor
Azienda Usl di Bologna
Brief Summary

The purpose of the investigators study is to create the evidence of effectivness on climacteric syndrome in patients affected by breast cancer, by acupuncture added to the standard care (self care).

Detailed Description

The study will be performed under randomized, open, controlled design. The effect of acupuncture and control group will be compared including the following outcomes: Greene climacteric scale score, quality of life (MenQol italian version), overall improvement in climacteric syndrome, adverse effects from treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
190
Inclusion Criteria
  • breast cancer
  • thermoregulation symptoms from at least 6-8 weeks - at least 6 hot flushes a day
  • climateric simptoms
  • age from 18 to 65 years
  • spontaneous or caused by chemotherapy amenorrea
  • hormone therapy for breast cancer
  • Green climateric scale score = or > of 15
  • performance status Eastern Cooperative Oncology Group (ECOG) < or = to 1
  • the patient agrees to follow physical exercice
  • diet and self-help groups
Read More
Exclusion Criteria
  • Hormone substitutive Therapy (TOS) during the last month
  • other systemic treatments for climateric syndrome (tibolone, antidepressants, homeopathy)
  • chemotherapy or radiotherapy
  • patients who refuses acupuncture
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
acupunctureacupuncture10 acupuncture sessions
self careself carepsychological support, phisical exercice, diet, self care groups
Primary Outcome Measures
NameTimeMethod
Greene climacteric scalebaseline ( 14 days before randomization) , between the 5th and 6th session af acupunture(only for experimental arm) at 14 weeks after randomization and at 3 and at 6 month after randomization for both arms.

Greene's score as measure for severity of menopausal symptoms. Change in the number of hot flashes.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

U.O. Medicina Oncologica - Ospedale Santa Maria Nuova Reggio Emilia

🇮🇹

Reggio Emilia, Italy

Dipartimento Anestesia, rianimazione, terapia del dolore e comparto operatorio,

🇮🇹

Piacenza, Italy

Oncologic Medicine, Carpi Hospital

🇮🇹

Carpi, Modena, Italy

Unità operativa (U.O.) salute donna infanzia e adolescenza e Unità operativa Consultori

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath